Skip to content

Autostattmii Anti-Dsdna

by Cogent Diagnotics, Ltd.

510(k) K952567

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 5 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 5 Oct 2026. What this means

Regulatory status

as of registry sync 5 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK952567 Date4 Mar 1997ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 5 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LRM
FDA applicant
Cogent Diagnotics , Ltd.
Device Class
Class II
Regulation
21 CFR Part 866.5100
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The AutoStat II Anti-DSDNA is an enzyme-labeled anti-DNA antibody assay designed for the quantitative detection of antibodies to double-stranded DNA (anti-DSDNA). This in vitro diagnostic device is classified under the nomenclature category of Anti-DNA Antibody (Enzyme-Labeled), Antigen, Control, and is intended for use in immunology testing.

This device is supplied as a reagent kit for laboratory use and is intended for single-use. It is regulated under FDA 510(k) clearance (K952567) as a Class 2 medical device under the Traditional pathway, with a product code of LRM. The assay is intended for use in clinical settings to aid in the diagnosis or monitoring of autoimmune diseases, such as systemic lupus erythematosus (SLE). Sterility and storage conditions are not specified in the provided data.

Other devices from Cogent Diagnotics, Ltd.

See all devices from Cogent Diagnotics, Ltd. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the AutoStat II Anti-DSDNA assay used for?

    The AutoStat II Anti-DSDNA is an enzyme-labeled antibody assay designed for the quantitative detection of antibodies to double-stranded DNA (anti-DSDNA). It is primarily used in clinical settings to assist with the diagnosis or monitoring of autoimmune diseases, such as systemic lupus erythematosus (SLE). By measuring anti-DSDNA levels, clinicians can better evaluate disease activity or progression.

  • How is the AutoStat II Anti-DSDNA supplied, and is it single-use?

    The AutoStat II Anti-DSDNA is supplied as a reagent kit intended exclusively for laboratory use. According to the provided data, it is designed for single-use only, meaning each kit should not be reused after opening or testing.

  • What regulatory pathway does the AutoStat II Anti-DSDNA follow?

    The AutoStat II Anti-DSDNA is regulated under the FDA’s Traditional 510(k) pathway and has received clearance (K952567) as a Class 2 medical device. This classification and clearance route indicate that the device is deemed substantially equivalent to a predicate device already on the market, ensuring it meets established safety and performance standards for in vitro diagnostic use.

  • Does the AutoStat II Anti-DSDNA come with controls, and what role do they play?

    Yes, the AutoStat II Anti-DSDNA kit includes controls as part of its design. Controls are essential for validating the assay’s performance, ensuring accuracy, and confirming that the test is functioning correctly before and during use. They help verify the reliability of results by providing reference values for comparison.

  • What immunology specialty does the AutoStat II Anti-DSDNA fall under?

    The AutoStat II Anti-DSDNA is categorized under the immunology specialty, specifically within the classification of enzyme-labeled anti-DNA antibody assays. This classification aligns with its intended use in diagnosing or monitoring autoimmune conditions, where antibody detection plays a critical role in clinical decision-making.